BI
SUPN icon

Binnacle Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Binnacle Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$526 Buy
+11
New +$443 ﹤0.01% 849
2025
Q2 		– Sell
-11
Closed -$360 – 851
2025
Q1 		$360 Buy
+11
New +$390 ﹤0.01% 735

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Binnacle Investments's SUPN Position: Q3 2025 in Review

Binnacle Investments opened a new position in Supernus Pharmaceuticals (SUPN) in Q3 2025: 11 shares worth $526. The stake represents ﹤0.01% of the portfolio and ranks #849 among its holdings. This is a return to the name: Binnacle Investments previously reported a position in SUPN as recently as Q1 2025.

Binnacle Investments first reported a position in SUPN in Q1 2025 and has held it in 2 quarters since. 310 funds tracked by Wall St. Rank hold SUPN as of Q3 2025.

  • Binnacle Investments held 11 shares of Supernus Pharmaceuticals worth $526 as of Q3 2025.
  • Supernus Pharmaceuticals was a new Binnacle Investments position in Q3 2025.
  • Supernus Pharmaceuticals made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #849 holding.
  • Binnacle Investments first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 310 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.